Clinical Trials Directory

Trials / Unknown

UnknownNCT00888758

Comparison of Biolimus A9 and Everolimus Drug-Eluting Stents in Patients With ST Segment Elevation Myocardial Infarction

Randomized Comparison of Biolimus-Eluting and Everolimus-Eluting Stents With Optical Coherence Tomography Guided Stent Implantation in ST Elevation Myocardial Infarction.A 9-Month Angiographic and Optical Coherence Tomography Follow-up.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Masaryk University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is: * comparison of a safety and effectiveness of third generation DES (biolimus A9 and everolimus) in patients with STEMI treated by primary PCI with OCT guidance. A rate of 9 month MACE (deaths, myocardial infarction, ischemia driven TLR) will be assessed in both groups. The secondary outcomes are a comparison of (using OCT): * number of uncovered stent struts * number of malapposed stents struts * in-stent neointimal volume * in-segment assessment of vessel wall response to DES

Detailed description

The aim of this multicenter, prospective, randomized trial with a core lab analysis is to assess the safety and effectiveness (at 9-month follow-up) of third generation DES (biolimus A9 and everolimus) in patients with evolving STEMI with the OCT guidance (to optimize a stent implantation) A serial OCT analysis will be performed to assess the number of either uncovered or malaposed stents strut and a degree of in-stent neointimal hyperplasia. Furthermore, the in-segment vessel wall response to DES implantation will also be analysed. The goal is to enroll 400 patients (200 in each group) with OCT guidance in 100 patients in each group.

Conditions

Interventions

TypeNameDescription
DEVICEbiolimus A9200 patients with STEMI will be treated using Biomatrix stent.
DEVICEeverolimus200 patients with STEMI will be treated with PROMUS DES.

Timeline

Start date
2009-05-01
Primary completion
2011-01-01
Completion
2011-05-01
First posted
2009-04-28
Last updated
2009-05-01

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT00888758. Inclusion in this directory is not an endorsement.